| 1 |
30114698 | The Role of the Acute Octreotide Suppression Test in Detecting Patients with Neuroendocrine Neoplasms. | 2018 |
1 |
| 2 |
26293797 | Possible role of TGF β1 in inflammatory pseudotumor associated with multiple neuroendocrine tumors of the small intestine. | 2015 Oct |
1 |
| 3 |
25012983 | Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures. | 2014 Oct |
1 |
| 4 |
25136449 | Catecholamine-secreting carotid body paraganglioma: successful preoperative control of hypertension and clinical symptoms using high-dose long-acting octreotide. | 2014 |
1 |
| 5 |
20372113 | Plasma chromogranin A response to octreotide test: prognostic value for clinical outcome in endocrine digestive tumors. | 2010 Sep |
1 |
| 6 |
20480408 | A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia. | 2010 Oct |
3 |
| 7 |
20572298 | Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors. | 2010 Jun 28 |
1 |
| 8 |
19337629 | The role of serum chromogranin A in diarrhoea predominant irritable bowel syndrome. | 2009 Mar |
2 |
| 9 |
19382304 | Serum chromogranin A reflects regression of metastatic carcinoid during prolonged octreotide treatment. | 2009 Apr |
1 |
| 10 |
19688980 | Primary hepatic leiomyosarcoma in a young man after Hodgkin's disease: diagnostic pitfalls and therapeutic challenge. | 2009 May-Jun |
1 |
| 11 |
20611009 | Serum chromogranin A reflects regression of metastatic carcinoid during prolonged octreotide treatment. | 2009 Apr |
1 |
| 12 |
17578828 | Octreotide suppression test in diagnosing and predicting the outcome of therapy in patients with neuroendocrine tumors. Preliminary report. | 2007 Mar-Apr |
4 |
| 13 |
17003646 | Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency. | 2006 Oct |
1 |
| 14 |
17274678 | Evaluation of chromogranin A expression in patients with non-neuroendocrine tumours. | 2006 |
4 |
| 15 |
7630318 | Comparison of chromogranin A and pancreastatin levels in plasma of patients with pancreatic islet cell tumor. | 1995 |
1 |
| 16 |
7771503 | Case report: diabetic ketoacidosis in a patient with glucagonoma. | 1995 Jun |
1 |
| 17 |
8186658 | The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth. | 1994 Jan |
1 |
| 18 |
2778040 | Effects of sandostatin on plasma chromogranin-A levels in neuroendocrine tumors. | 1989 Oct |
5 |